Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 56 clinical trials
None
Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers

of anti-VEGF (bevacizumab, ranibizumab and aflibercept) against these choroidal neovessels. However, some eyes appear to respond less well or be resistant to anti-VEGF injections, which affects

  • 0 views
  • 26 Jan, 2021
  • 1 location
None
Aflibercept in Recurrent or Persistent CNV

to the current routine therapy using aflibercept in eyes with treatment naive, recurrent or persistent nAMD, treatment naive diabetic retinopathy and pretreated diabetic retinopathy. 20

wet age-related macular degeneration
fundus photography
retinopathy
age-related macular degeneration
optical coherence tomography
  • 14 views
  • 26 Mar, 2021
  • 1 location
None
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

This is a prospective, observational, multi-center and post-authorization safety study that includes patients with a diagnosis of Neovascular Glaucoma. The investigator will have made the decision to use Eylea for treatment. The objective of this study is to assess safety and effectiveness of Eylea using in real clinical practice. Patients …

  • 0 views
  • 06 Oct, 2021
  • 1 location
None
Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

The study aims to collect data on the safety and use of intravitreal aflibercept injections into the eye for the treatment of eye disorders that cause blurred vision or a blind spot due to

  • 0 views
  • 19 Oct, 2021
  • 1 location
None
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics

The objective of this research is to determine the effects of anti-VEGF drugs (bevacizumab, ranibizumab or aflibercept) on aqueous humor dynamics (AHD) in patients with retinal vascular disease

  • 0 views
  • 29 May, 2021
  • 2 locations
None
Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography

group is patients that have neovascular age-related macular degeneration and have had treatment with aflibercept for this condition. This is a single-site study and does not involve any masking

age-related macular degeneration
optical coherence tomography
diabetic retinopathy
vegf
aflibercept
  • 0 views
  • 25 Aug, 2021
  • 1 location